The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome

被引:12
|
作者
Menke, Leonie A. [1 ,2 ]
Sas, Theo C. J. [1 ,3 ,4 ]
Zandwijken, Gladys R. J. [2 ]
de Ridder, Maria A. J. [5 ]
Stijnen, Theo [6 ]
Keizer-Schrama, Sabine M. P. F. de Muinck [3 ]
Otten, Barto J. [7 ]
Wit, Jan M. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Paediat, NL-2300 RC Leiden, Netherlands
[2] Dutch Growth Res Fdn, Rotterdam, Netherlands
[3] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Paediat, Rotterdam, Netherlands
[4] Albert Schweitzer Hosp, Dept Paediat, Dordrecht, Netherlands
[5] Erasmus MC, Dept Biostat, Rotterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Biostat, NL-2300 RC Leiden, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
关键词
AGE REFERENCES; SHORT STATURE; MUSCLE MASS; CHILDREN; HEIGHT; RATIO; FAT;
D O I
10.1111/j.1365-2265.2010.03789.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Objective Untreated girls with Turner syndrome (TS) have short stature, relatively broad shoulders, a broad pelvis, short legs, a high fat mass and low muscle mass. Our objective was to assess the effect of the weak androgen oxandrolone (Ox) on body proportions and composition in growth hormone (GH)-treated girls with TS. Design/Patients 133 patients were included in a randomized, placebo-controlled, double-blind study. Methods Patients were treated with GH (1 center dot 33 mg/m2 per day) from baseline, combined with placebo (Pl) or Ox in a low (0 center dot 03 mg/kg per day) or previously conventional (0 center dot 06 mg/kg per day) dose from the age of eight, and oestrogens from the age of twelve. Sitting height, biacromial and biiliacal distances compared with height (i.e. shape values), BMI, waist circumference, sum of 4 skinfolds (sum4skin) and upper arm muscle area (UAMA) SD scores (SDS) were assessed half-yearly. Results Compared with GH + Pl, adult shape values on GH + Ox tended to be higher for sitting height (Ox 0 center dot 03, P = 0 center dot 2; Ox 0 center dot 06, P = 0 center dot 02) and biacromial distance (Ox 0 center dot 03, P = 0 center dot 2; Ox 0 center dot 06, P = 0 center dot 07) and lower for biiliacal distance (Ox 0 center dot 03, P = 0 center dot 004; Ox 0 center dot 06, P = 0 center dot 08). Sum4skin SDS tended to decrease more (Ox 0 center dot 03, P = 0 center dot 2; Ox 0 center dot 06, P = 0 center dot 005) while UAMA SDS increased more (Ox 0 center dot 03, P < 0 center dot 001; Ox 0 center dot 06, P < 0 center dot 001) than on GH + Pl. The increase in BMI and waist circumference SDS was comparable between the dosage groups. Conclusions In GH-treated girls with TS, Ox 0 center dot 06 increases sitting height and tends to increase biacromial distance and decrease biiliacal distance, while Ox 0 center dot 03 significantly decreases biiliacal distance compared with height. Furthermore, Ox 0 center dot 06 reduces subcutaneous fat mass, and both Ox dosages increase muscle mass.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 50 条
  • [31] Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial
    Sas, TCJ
    Gerver, WJM
    de Bruin, R
    Stijnen, T
    Keizer-Schrama, SMPFD
    Cole, TJ
    van Teunenbroek, A
    Drop, SL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12): : 4622 - 4628
  • [32] Effect of oxandrolone therapy on adult height in Turner syndrome patients treated with growth hormone: a meta-analysis
    Sheanon, Nicole M.
    Backeljauw, Philippe F.
    INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2015,
  • [33] Prediction of final height in girls with Turner syndrome treated with growth hormone
    Morin, A
    Guimarey, L
    Santucci, Z
    Apezteguia, M
    MEDICINA-BUENOS AIRES, 2000, 60 (05) : 551 - 554
  • [34] Experience With 68 Girls With Turner's Syndrome and Evaluation of Final Height in 26 Patients Treated With Growth Hormone in Combination or Without Oxandrolone
    Moayeri, H.
    Hakimi, Amir G. H.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2005, 3 (04) : 193 - 198
  • [35] Prevalence and changes in genetic and clinical abnormalities in growth hormone-treated girls with Turner syndrome: a study from the Belgian-Luxembourgish growth hormone registry (BELGROW)
    Boutsen, Laure
    Thomas, Muriel
    De Schepper, Jean
    Verlinde, Fransiska
    Beckers, Dominique
    Heinrichs, Claudine
    Casteels, Kristina
    Cools, Martine
    Dotremont, Hilde
    Brachet, Cecile
    Parent, Anne-Simone
    Lambert, Sophie
    Massa, Guy
    Klink, Daniel
    Logghe, Karl
    Depoorter, Sylvia
    Fudvoye, Julie
    Reynaert, Nele
    Becker, Marianne
    Lysy, Philippe
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 410 - 411
  • [36] Effect of growth hormone and oxandrolone treatment on glucose metabolism in Turner syndrome -: A longitudinal study
    Joss, EE
    Zurbrügg, RP
    Tönz, O
    Mullis, PE
    HORMONE RESEARCH, 2000, 53 (01) : 1 - 8
  • [37] 3-YEAR RESULTS OF TREATMENT WITH GROWTH-HORMONE, ALONE OR ASSOCIATED WITH OXANDROLONE, IN GIRLS WITH TURNER SYNDROME
    JOB, JC
    LANDIER, F
    HORMONE RESEARCH, 1991, 35 (06) : 229 - 233
  • [38] Age-related perception of stature, acceptance of therapy, and psychosocial functioning in human growth hormone-treated girls with Turner's syndrome
    Lagrou, K
    Xhrouet-Heinrichs, D
    Heinrichs, C
    Craen, M
    Chanoine, JP
    Malvaux, P
    Bourguignon, JP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05): : 1494 - 1501
  • [39] Final height and body composition in growth hormone-treated short Greek children born small for gestational age
    Xatzipsalti, Maria
    Maggina, Paraskevi
    Panagiotou, Evangelos
    Polychroni, Ioanna
    Delis, Dimitris
    Stamogiannou, Lela N.
    HORMONE RESEARCH, 2009, 72 : 378 - 378
  • [40] Predictors of Adult Height in Girls with Turner Syndrome Treated with Growth Hormone † 408
    Steven D Chernausek
    Kenneth M Attie
    James W Frane
    Pediatric Research, 1998, 43 (Suppl 4) : 72 - 72